Literature DB >> 29630124

Study of candidate gene cHRNA4 for familial epilepsy syndrome.

N Wang1, H-L Huang, H Zhou.   

Abstract

OBJECTIVE: To screen a three-generation familial partial epilepsy with variable foci (FPEVF) family with epilepsy to identify the cHRNA4 gene (a candidate gene). PATIENTS AND METHODS: A total of 18 members of the three-generation FPEVF family with partial epilepsy were selected, and 18 blood samples were collected for investigation. Among them, five members were affected by epilepsy, and another 13 members were not affected. A pedigree chart was mapped to comprehensively analyze the clinical characteristics of each member, including ictal semiology, electroencephalogram (EEG), past medical history, MRI features, neuropsychological MMSE (mini-mental state examination) scores, etc. PCR and Sanger sequencing method were used to screen the mutant gene cHRNA4.
RESULTS: cHRNA4 genes of all affected members were positively mutated, and that of the unaffected members were negative. The positive mutation was base A instead of base G.
CONCLUSIONS: cHRNA4 is the causative gene of FPEVF, and genes of the affected members are all heterozygotes mutations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630124     DOI: 10.26355/eurrev_201803_14594

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Next Generation Sequencing Identify Rare Copy Number Variants in Non-syndromic Patent Ductus Arteriosus.

Authors:  Bo Chen; Aiping Hou; Lin Zhao; Ying Liu; Xin Shi; Bowen Du; Yu Yu; Pengjun Zhao; Ying Gao
Journal:  Front Genet       Date:  2020-11-12       Impact factor: 4.599

Review 2.  Cholinergic Signaling, Neural Excitability, and Epilepsy.

Authors:  Yu Wang; Bei Tan; Yi Wang; Zhong Chen
Journal:  Molecules       Date:  2021-04-13       Impact factor: 4.411

3.  Genetic Interaction of H19 and TGFBR1 Polymorphisms with Risk of Epilepsy in a Chinese Population.

Authors:  Zhaoshi Zheng; Yayun Yan; Qi Guo; Libo Wang; Xuemei Han; Songyan Liu
Journal:  Pharmgenomics Pers Med       Date:  2021-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.